Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in The New York Times on December 17, 2010 titled “Court Backs Patents for Diagnostic Tests.” Brinckerhoff discusses a Court of Appeals for the Federal Circuit ruling which upholds that diagnostic tests used to determine whether a patient is getting the proper dose of a medicine can be patented. She states that the decision will be welcomed by those working in personalized medicine and may help improve both the clinical efficacy and cost-efficiency of therapeutic treatment.